Skip to content

Phadezym Ige Prist Test

by Pharmacia, Inc.

510(k) K810507

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK810507 Date20 Mar 1981ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DGC
Device Class
Class II
Regulation
21 CFR Part 866.5510
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Phadezym Ige Prist Test is an immunology device categorized as an IgE, antigen, antiserum, and control. It is designed for use in clinical laboratory settings to assist in the detection and measurement of immunoglobulin E.

This device is manufactured by Pharmacia, Inc. and has received FDA 510(k) clearance under the product code DGC. It is classified as a Class II medical device subject to special controls.

Other devices from Pharmacia, Inc.

See all devices from Pharmacia, Inc. →

Questions

AI-generated answers, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Phadezym IgE PRIST Test?

    This device is designed for use in clinical laboratory settings to assist healthcare professionals in the detection and measurement of immunoglobulin E (IgE) in patient samples.

  • What is the regulatory status of this device?

    The Phadezym IgE PRIST Test is a Class II medical device that has received FDA 510(k) clearance under the product code DGC, indicating it has been found substantially equivalent to legally marketed predicate devices.

  • Which medical specialty is this test associated with?

    This device is categorized under the immunology medical specialty, as it is used to identify and quantify specific immunological components, specifically IgE, antigens, antisera, and controls.